Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03719092 · ClinicalTrials.gov registry record · NA
High Dose Vitamin A in Preventing Gastrointestinal GVHD in Participants Undergoing Donor Stem Cell Transplant
A NA study of Allogeneic Hematopoietic Stem Cell Transplantation Recipient, sponsored by Ohio State University Comprehensive Cancer Center.
- Active
- Registry status
- NA
- Development phase
- 62
- Enrollment target
- 1
- Study location
NCT03719092 is a NA study of Allogeneic Hematopoietic Stem Cell Transplantation Recipient that is active but no longer recruiting, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 62 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03719092, a NA study of Allogeneic Hematopoietic Stem Cell Transplantation Recipient, is active but no longer recruiting, sponsored by Ohio State University Comprehensive Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 62 participants
- Enrollment target
- 1
- Study location
Study Summary
This phase I trial studies the side effects and how well high dose vitamin A works in preventing gastrointestinal graft versus host disease (GVHD) in participants undergoing donor stem cell transplant. Vitamin A deficiency is associated with increased risk of gastrointestinal GVHD. Vitamin A regulates growth and differentiation of intestinal cells and may reduce risk of gastrointestinal GVHD.
Conditions Studied
Interventions
- OTHER Best Practice
- DIETARY_SUPPLEMENT Vitamin A Compound
Study Locations (1)
Ohio
- Ohio State University Comprehensive Cancer Center - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2020-02-07 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03719092
The ClinicalTrials.gov registry entry for NCT03719092 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University Comprehensive Cancer Center, which has 341 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Allogeneic Hematopoietic Stem Cell Transplantation Recipient appearing as the primary indexed condition, and to 2 interventions - of which Best Practice is the first listed.
NCT03719092 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT03719092 about?
NCT03719092 is a clinical study titled "High Dose Vitamin A in Preventing Gastrointestinal GVHD in Participants Undergoing Donor Stem Cell Transplant". This phase I trial studies the side effects and how well high dose vitamin A works in preventing gastrointestinal graft versus host disease (GVHD) in participants undergoing donor stem cell transplant. Vitamin A deficiency is associated with increased risk of gastrointestinal GVHD. Vitamin A regulat...
What is the current status of trial NCT03719092?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 62 participants. The study started on 2020-02-07. Estimated completion is 2026-12-31.
What conditions does trial NCT03719092 study?
This clinical trial studies the following conditions: Allogeneic Hematopoietic Stem Cell Transplantation Recipient.
What interventions are being tested in trial NCT03719092?
The interventions under investigation include: Best Practice (OTHER), Vitamin A Compound (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03719092?
This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03719092 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Allogeneic Hematopoietic Stem Cell Transplantation Recipient
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
RECRUITING · Phase 2
-
Donor Virus-Specific CMV or AdV CTL to Treat CMV or AdV Reactivation or Disease After Solid Organ or HCT
RECRUITING · Early Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.